Vitae Pharmaceuticals, Inc. to Present at the 30th Annual JP Morgan Healthcare Conference  
1/5/2012 8:00:25 AM

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals today announced it will present at the JP Morgan Healthcare Conference on Thursday, January 12, 2012 at 9:30 a.m. Pacific Time in San Francisco, CA. Vitae's President and Chief Executive Officer, Jeffrey Hatfield, will provide an overview on the company and its clinical programs, including VTP-27999 for chronic kidney disease.